SPECIAL NOTICE
A -- Acute Care Cover for Severely Injured Limbs - 14-SN-0003
- Notice Date
- 12/5/2013
- Notice Type
- Special Notice
- NAICS
- 541712
— Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Contracting Office
- Department of the Navy, Office of Naval Research, ONR, CODE ONR-02, 875 North Randolph St., Suite 1425, Arlington, Virginia, 22203-1995
- ZIP Code
- 22203-1995
- Solicitation Number
- 14-SN-0003
- Archive Date
- 2/11/2014
- Point of Contact
- Sean M Palmer,
- E-Mail Address
-
sean.m.palmer@navy.mil
(sean.m.palmer@navy.mil)
- Small Business Set-Aside
- N/A
- Description
- 14-SN-0003 12/05/2013 The Office of Naval Research (ONR) is interested in receiving proposals for the initial development of the "Acute Care Cover for Severely Injured Limbs" (ACCSIL). ACCSIL will be an advanced field dressing with capabilities beyond those currently available today for battlefield care of severely injured arms or legs. It is intended for application by corpsmen/medics/first responders at the point of injury and removal by medical care providers at Medical Treatment Facilities (MTF) that can provide definitive care. ACCSIL is intended for use on a wide variety of severe injuries including: avulsions, amputations, lacerations, compound and other fractures, thermal and chemical burns, deglovings, deep and widespread abrasions, etc. This product will preserve viable tissue and diminish post-injury, negative, secondary sequelae in order to reduce morbidity and mortality. ACCSIL is intended to preserve the tissues of the injured limb in the best possible state during delays prior to evacuation and during evacuation itself. Optimally, at the time ACCSIL is removed, the limb, although injured, will be as fresh, well perfused, viable, and uninfected as at the moment of injury. The final product will consist of two independent components: a) a conformal cover to serve as a physical barrier to contain/protect the remaining tissue, and b) an internal bioactive coating consisting of several pharmacological interventions to mitigate progressive injury and aid in preserving tissue, limb and systemic health. Each of the two components, the conformal cover and the internal bioactive coating, should be considered separate products that can be developed and utilized alone. However, the intention is to combine the products into a single solution with the conformal cover and internal bioactive coating integrated, packaged and applied together. Applicants shall apply using ONRBAA14-001.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/DON/ONR/ONR/14-SN-0003/listing.html)
- Record
- SN03246345-W 20131207/131205234827-d379e8472935a7b17658bee2bde27dbf (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |